Improving Treatments - Improving Lives

Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. Veloxis' unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO.


Mar 3, 2015
Release of Annual Report 2014

PDF Veloxis Annual report 2014
 926.9 KB   Add to Briefcase
PDF Presentation
 404.1 KB   Add to Briefcase
Webcast Audiocast

To access the live conference call, please dial one of the following numbers:

+45 32 72 80 18 (Denmark)

+44 (0) 1452 555 131 (UK)

+1 866 682 8490 (USA)

Access code 88916362

Efforts to Obtain FDA Approval

Stock Information